News | RIVM

Chromium-6 from medical implants not harmful to health

Chromium-6 from medical implants, such as hip or knee implants, does not result in severe health damage.

Most reports received by MEBI in 2021 concerned copper IUDs

More reports of suspected adverse effects from copper intrauterine devices (IUDs) were made in 2021 than in previous years, according to the annual report of the Dutch reporting and expertise centre for adverse effects of medical implants (MEBI).

uitgestoken hand van arts met daarin een koperspiraaltje

Shortcomings in the technical documentation of mesh implants intended to treat pelvic organ prolapse used in the Netherlands

After a detailed assessment of the technical documentation of 9 different mesh implants intended to treat pelvic organ prolapse used in NL (2018) RIVM concludes that the safety and performance of these products were not properly substantiated.

More reports of adverse effects of implants in 2019

In 2019, the Dutch reporting centre for adverse effects of medical implants (MEBI) received 397 reports of suspected adverse effects. The reports concerned 462 implants.

Mesh implants intended to treat pelvic organ prolapse

Synthetic mesh are used to treat patients with pelvic organ prolapse.

Summary International Expert Meeting on breast implant-associated lymphoma

On November 19th 2018, RIVM organised an international expert meeting on a rare type of lymphoma that is associated with breast implants.

RIVM and German BfR enter cooperation agreement on animal protection and food safety

The German Federal Institute of Risk Assessment (BfR) and the Dutch National Institute for Public Health and the Environment, RIVM have signed a cooperation agreement, focused on developing new sci

Breakthrough on cumulative risk assessment exposure to pesticides in food

The European Commission, Member States and EFSA have taken a major step forward in their work on assessing the cumulative risks from exposure to pesticides in food.

Nanotechnology increasingly used in medical devices

The application of nanotechnology to design and produce medical devices is increasing. RIVM provides an overview of nanotechnology enabled medical devices.

RIVM Nutrition and Food Safety expert gets top risk assessment function at EFSA

As of November 1, Prof. Hans Verhagen will join the European Food Safety Authorithy (EFSA) in Parma, Italy as Head of the Risk Assessment and Scientific Assistance Department (RASA).